Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Patent
1995-06-05
1998-01-06
McDermott, Corrine M.
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
6048911, A61M 3100
Patent
active
057049106
ABSTRACT:
Disclosed is an implantable device for delivering a pre-selected molecule, for example, a hormone, into a mammal's systemic circulation. The device comprises a blood permeable element that can be anchored to an inner wall of an intact blood vessel. The device also comprises a capsule that is held in place within the blood vessel by the anchored blood permeable element. The capsule encloses viable cells which produce and secrete the pre-selected molecule into blood passing the capsule. The invention also provides a minimally invasive method for percutaneously introducing into a preselected blood vessel the device of the invention.
REFERENCES:
patent: 3313289 (1967-04-01), Kapral
patent: 3952747 (1976-04-01), Kimmell, Jr.
patent: 4309776 (1982-01-01), Berguer
patent: 4378016 (1983-03-01), Loeb
patent: 4393133 (1983-07-01), Knowles et al.
patent: 4479796 (1984-10-01), Kallok
patent: 4494531 (1985-01-01), Gianturco
patent: 4586922 (1986-05-01), Theeuwes
patent: 4771773 (1988-09-01), Kropf
patent: 4781177 (1988-11-01), Lebigot
patent: 4793348 (1988-12-01), Palmaz
patent: 4793825 (1988-12-01), Benjamin et al.
patent: 4817600 (1989-04-01), Herms et al.
patent: 4994069 (1991-02-01), Ritchart et al.
patent: 5026365 (1991-06-01), Rossini et al.
patent: 5053008 (1991-10-01), Bajaj
patent: 5059205 (1991-10-01), El-Nounou et al.
patent: 5104399 (1992-04-01), Lazarus
patent: 5147379 (1992-09-01), Sabbaghian et al.
patent: 5152777 (1992-10-01), Goldberg et al.
patent: 5164186 (1992-11-01), Tsuru et al.
patent: 5182111 (1993-01-01), Aebischer et al.
patent: 5304120 (1994-04-01), Crandell et al.
patent: 5314471 (1994-05-01), Brauker et al.
patent: 5350398 (1994-09-01), Pavcnik et al.
patent: 5383887 (1995-01-01), Nadal
patent: 5383892 (1995-01-01), Cardon et al.
patent: 5443508 (1995-08-01), Gianpapa
patent: 5487739 (1996-01-01), Aebischer et al.
Kurachi et al. (1993) "Gene Therapy of Hemophilia B" Thromb. Haemost., 70:193-197.
Yao et al.(1992) "Expression of Human Factor IX in Mice After Rejection of Genetically Modified Myoblasts," Proc. Natl. Acad. Sci., 89:3357-3361.
Yao et al. (1993) "Implanted Myoblasts Not Only Fuse With Myofibers But Also Survive As Muscle Precursor Cells, " Journal of Cell Science, 105:957-063.
Yao et al. (1994) "Primary Myoblast-mediated Gene Transfer: Persistent Expression of Human Factor IX In Mice," Gene Therapy, 1:99-107.
Copy of International Search Report for counterpart International application PCT/US96/08524.
Aebischer et al. (1991) "Transplantation of Microencapsulated Bovine Chromaffin Cells Reduces Lesion-induced Rotational Asymmetry in Rats," Brain Research560: 43-49.
Albert et al. (1992) "Evaluation of Various Gene Transfection Methods Into Human Myoblast Clones," Transplantaation Proceedings 24: 2784-2786.
Crystal, R.G. (1992) "Gene Therapy Strategies for Pulmonary Disease," The American Journal of Medicine 92: 6-44S-6A-52S.
Dwarki et al. (1995) "Gene Therapy for Hemophilia A: Production of Therapeutic Levels of Human Factor VIII in vivo in Mice," Proc. Natl. Acad. Sci. USA 92: 1023-1027.
Garver et al. (1987) "Clonal Gene Therapy: Transplanted Mouse Fibroblast Clones Express Human .alpha.1-Antitrypsin Gene in Vivo," Science 237: 762-764.
Glaser, V. (1995) "Bioreactor and Fermenter Suppliers" Genetic Engineering News Feb. 1, 1995.
Goldberg et al.(1987) "The Regulated Expression of Erythropoietin by Two Human Hepatoma Cell Lines," Proc. Natl. Acad. Sci. USA84: 7972-7976.
Greenfield et al. (1973) "A New Intracaval Filter Permitting Continued Flow and Resolution of Emboli," Surgery 73:599-606.
Greenfield et al. (1977) "Clinical Experience with the Kim-Ray Greenfield Vena Caval Filter," Ann. Surg. 185: 692-698.
Greenfield et al.(1981) "Greenfield Vena Caval Filter Experience," Arch Surg116: 1451-1456.
Greenfield et al. (1989) "Venous Interruption," Chapter 68 in Haimovici's Vascular Surgery Principles and Techniques, 3rd Ed pp. 929-940.
Greenfield L.J. (1991) "Venous Thromboembolic Disease, " Chapter 37 in Vascular Surgery, A Comprehensive Review, Moore, Ed., pp. 669-679.
"Instructions for Use Titanium Greenfield Vena Cava Filter with 12 French Introducer System" 1-48, by Meditech, Boston Scientific Corporation.
Hamamori et al.(1995) "Myoblast Transfer of Human Erythropoietin Gene in Mouse Model of Renal Failure," J. Clin. Invest. 95: 1808-1813.
Hoeben et al. "Toward Gene Therapy in Haemophilia A: Retrovirus-Mediated Transfer of a Factor VII Gene into Murine Haematopoietic Progenitor Cells," 341-345.
Jelkmann, W. (1992) "Erythropoietin: Structure, Control of Production, and Function," Physiological Reviews 72: 449-489.
Lacy et al. (1976) "Long-term Perifusion of Isolated Rat Islets in Vitro," Diabetes25: 484-493.
Lozier et al. (1994) "Gene Therapy and the Hemophilias," JAMA 271: 47-51.
Maxwell et al. (1993) "Identification of the Renal Erythropoietin-producing Cells Using Transgenic Mice," Kidney International44: 1149-1162.
Nashitz et al. (1993) "Thromboembolism in Cancer, " Cancer 71: 1384-1390.
Radovich, J.M. (1995) "Composition of Polymer Membranes for Therapies of End-Stage Renal Disease," Bonomini V, Berland Y (eds): Dialysis Membranes: Structure and Predictions. Contrib Nephrol. Basel, Karger 113: 11-24.
Roman et al. (1992) "Circulating Human or Canine Factor IX from Retrovirally Transduced Primary Myoblasts and Established Myoblast Cell Lines Grafted into Murine Skeletal Muscle," Somatic Cell and Molecular Genetics18: 247-258.
Tripathy et al. (1994) "Stable Delivery of Physiologic Levels of Recombinant Erythropoietin to the Systemic Circulation by Intramuscular Injection of Replication-defective Adenovirus," Proc. Natl. Acad. Sci. USA 91; 11557-11561.
Wollheim et al.(1990) "Isolation of Pancreatic Islets and Primary Culture of the Intact Microorgans or of Dispersed Islet Cells," Methods in Enzymology 192: 188-223.
Wollheim et al. (1990) "Establishment and Culture of Insulin-Secreting .beta.Cell Lines" Methods in Enzymology 192: 223-225.
Blyveis Deborah
McDermott Corrine M.
Nephros Therapeutics, Inc.
LandOfFree
Implantable device and use therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Implantable device and use therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable device and use therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2324641